Mr. Shiladitya Sen engaged in research misconduct by knowingly and intentionally falsifying and/or fabricating data reported in the following published paper, his Ph.D. thesis, a poster presentation, and his mentor’s grant applications submitted to NIGMS, NIH.

Maria Cristina Miron Elqutub engaged in research misconduct by recording dates and providing her own blood samples to cause these samples to be falsely labeled as samples from ninety-eight (98) study subjects in a cancer genetics study involving human blood samples.

ORI found that Gareth John, Ph.D. engaged in research misconduct by knowingly and intentionally falsifying data reported in Development 141(12):2414-28, 2014 Jun.

The Office of Research Integrity (ORI) has appointed Dr. Ranjini Ambalavanar as Acting Director of the Division of Investigative Oversight. Since joining ORI in 2009, she has handled more than 100 allegations of research misconduct. She replaces Dr. Ann Hohmann, who successfully completed her 120-day detail appointment.

Dr. H.M. Krishna Murthy committed research misconduct in research supported by PHS grants. Dr. Murthy requested a hearing before an Administrative Law Judge (ALJ) of the Departmental Appeals Board to dispute the findings. The ALJ issued a recommended decision to the Acting Assistant Secretary for Health (ASH) granting summary judgment in favor of ORI and sustaining ORI’s proposal to impose a ten-year debarment and a ten-year ban...